Industry News

The National Bio and Agro-Defense Facility (NBAF) opened in May of 2023 in Manhattan, Kan. Enabling the rapid detection and mitigation of animal and human pathogens, the $1.25 billion complex provides state-of-the-art biocontainment labs supported by robust ventilation and decontamination systems. Sited on 48 acres adjacent to Kansas State University, the 708,000-sf development provides enhanced diagnostic and research capabilities to protect the country from emerging, zoonotic, and foreign animal diseases.

Stellenbosch University opened the $66 million Biomedical Research Institute (BMRI) in Cape Town in April of 2023. Located on the Tygerburg Campus, the 354,000–sf complex leverages an open design to foster active collaboration between researchers, staff, and students as they investigate the diseases that have the greatest impact on South Africa. Housing the Centre for Epidemic Response and Innovation, this high-performance research hub features a BSL-3 laboratory spanning 6,500 sf, the largest on the continent.

Dallas County Health and Human Services is planning to construct the $52 million Public Health Laboratory in the growing Southwestern Medical District. Designed by Page, the 75,000-sf structure will provide BSL-3 environments for the detection and mitigation of infectious disease agents and toxins. Centralizing lab services previously dispersed in several locations, the state-of-the-art building will utilize robust ventilation systems to ensure the safe handling of potentially hazardous and pathogenic materials.

Emory University opened the $313 million Health Science Research Building II in March of 2023 in Atlanta. Designed by HOK, the 350,000-sf facility provides world-class research environments for a range of specialties including biomedical engineering, cardiovascular medicine, oncology, inflammation, immunology, and emerging infections.

Moderna will break ground in mid-2023 on a £150 million complex for the creation of mRNA vaccines and therapeutics in the United Kingdom. Located on the Harwell Campus in Oxfordshire, the Moderna Innovation and Technology Centre (MITC) will comprise two 145,000-sf buildings. The Drug Substance Manufacturing Unit will leverage next-generation automation systems to produce high volumes of vaccine materials, accompanied by an early-stage R&D hub that will support clinical trials.